Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boxer

Showing results (161-170 of 328) with videos related to

Pageof 33
Sort By:
Brain : a Journal of Neurology|October 4, 2017
Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variantsKamalini G Ranasinghe, Leighton B Hinkley, Alexander J Beagle, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Frontiers in Aging Neuroscience|December 6, 2024
Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementiaJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 23, 2024
Comorbid neuropathology and atypical presentation of Alzheimer's diseaseStefanie D Pina-Escudero, Renaud La Joie, Salvatore Spina, et al.
Neuroimage. Clinical|November 22, 2017
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's DiseaseLeonardo Iaccarino, Gautam Tammewar, Nagehan Ayakta, et al.
Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS familyAdam L Boxer, Ian R Mackenzie, Bradley F Boeve, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
Uniform data set language measures for bvFTD and PPA diagnosis and monitoringAdam M Staffaroni, Sandra Weintraub, Katya Rascovsky, et al.
Nature Medicine|October 17, 2022
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Alzheimer'S Research & Therapy|August 29, 2024
Clinical implications of head trauma in frontotemporal dementia and primary progressive aphasiaBreton M Asken, Jessica M Bove, Russell M Bauer, et al.
Pageof 33

Showing results (161-170 of 328) with videos related to

Sort By:
Pageof 33
Brain : a Journal of Neurology|October 4, 2017
Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variantsKamalini G Ranasinghe, Leighton B Hinkley, Alexander J Beagle, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Frontiers in Aging Neuroscience|December 6, 2024
Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementiaJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 23, 2024
Comorbid neuropathology and atypical presentation of Alzheimer's diseaseStefanie D Pina-Escudero, Renaud La Joie, Salvatore Spina, et al.
Neuroimage. Clinical|November 22, 2017
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's DiseaseLeonardo Iaccarino, Gautam Tammewar, Nagehan Ayakta, et al.
Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS familyAdam L Boxer, Ian R Mackenzie, Bradley F Boeve, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
Uniform data set language measures for bvFTD and PPA diagnosis and monitoringAdam M Staffaroni, Sandra Weintraub, Katya Rascovsky, et al.
Nature Medicine|October 17, 2022
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Alzheimer'S Research & Therapy|August 29, 2024
Clinical implications of head trauma in frontotemporal dementia and primary progressive aphasiaBreton M Asken, Jessica M Bove, Russell M Bauer, et al.
Pageof 33